What causes Pelvic Inflammatory Disease (PID) in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Pelvic Inflammatory Disease in Women

Pelvic inflammatory disease (PID) is primarily caused by sexually transmitted pathogens, particularly Neisseria gonorrhoeae and Chlamydia trachomatis, along with a variety of anaerobic and aerobic bacteria that ascend from the lower genital tract to the upper genital tract. 1

Primary Causative Pathogens

Sexually Transmitted Organisms

  • Neisseria gonorrhoeae: Found in 27-80% of cervical samples from women with PID 1
  • Chlamydia trachomatis: Isolated from the cervix in 5-39% of women with PID 1
  • Mycoplasma genitalium: Emerging as an important pathogen in PID 2

Other Bacteria Commonly Involved (25-50% of cases)

  • Anaerobic bacteria:

    • Bacteroides species
    • Peptostreptococcus species
    • Peptococcus species
  • Aerobic/facultative bacteria:

    • Gardnerella vaginalis
    • Streptococcus species
    • Escherichia coli
    • Haemophilus influenzae 1

Pathogenesis of PID

PID develops through several key mechanisms:

  1. Direct canalicular spread: The primary route of infection is ascending spread from the endocervix to the endometrium and fallopian tubes 1

  2. Noncanalicular spread: Can occur via parametrial lymphatics 1

  3. Contributing factors that facilitate infection:

    • Uterine instrumentation (e.g., IUD insertion)
    • Hormonal changes during menstruation
    • Retrograde menstruation
    • Organism-specific virulence factors 1
    • Bacterial vaginosis (BV) - serves as an antecedent to polymicrobial PID 3

Clinical Implications and Risk Factors

  • Many women with PID have minimal or no symptoms ("silent PID"), which can still lead to serious reproductive consequences 3

  • After a single episode of PID:

    • Approximately 12% of women become infertile
    • Risk of ectopic pregnancy increases sevenfold
    • Risk of infertility increases dramatically with multiple episodes (25% after two episodes, over 50% after three or more) 3
  • Risk factors that increase likelihood of developing PID:

    • Multiple sexual partners
    • History of sexually transmitted infections
    • Young age (highest rates in women aged 15-24)
    • Non-use of barrier contraceptives 1

Important Clinical Considerations

  • The polymicrobial nature of PID means that treatment must provide broad-spectrum coverage 4

  • PID caused by Chlamydia tends to be more subtle or asymptomatic compared to gonococcal PID, making it more likely to go undetected and untreated 4

  • Both N. gonorrhoeae and C. trachomatis employ immune evasion mechanisms that allow them to survive within host epithelial cells and neutrophils 5

  • Early diagnosis and treatment are crucial to prevent long-term sequelae such as infertility, chronic pelvic pain, and ectopic pregnancy 6

  • Prevention strategies include:

    • Regular screening for chlamydial and gonococcal infections
    • Prompt treatment of cervicitis and bacterial vaginosis
    • Consistent condom use
    • Reduction in number of sexual partners 1

The polymicrobial nature of PID and the ability of causative organisms to evade host immune responses make this condition particularly challenging to diagnose and treat, highlighting the importance of prevention strategies and early intervention.

References

Guideline

Pelvic Inflammatory Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pelvic inflammatory disease.

Obstetrics and gynecology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.